Coronavirus Infections
10 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Infections, Virus Diseases
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Awake timed prone and repositioning for coronavirus infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fluvoxamine for coronavirus infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine for coronavirus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| hydroxychloroquine + azithromycin for coronavirus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oxygen-ozone therapy, probiotic supplementation and Standard of care + SivoMixx (200 billion) for coronavirus infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Position for coronavirus infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| prone positioning for coronavirus infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Positioning (PP) for coronavirus infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tradipitant for coronavirus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Wharton's jelly derived Mesenchymal stem cells. for coronavirus infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.